Eli Lilly and Company: Goldman Sachs maintains its neutral opinion







Marketzone with MT Newswires 2022

All the news about ELI LILLY AND COMPANY

Analyst recommendations on ELI LILLY AND COMPANY

2022 turnover 28,825M

28,381M
2022 net result 6,297M

6,200M
Net debt 2022 9,509M

9,362M
PER 202243.0x
2022 return1.30%
Capitalization 291 billion
291 billion
286 billion
VE / CA 202210.4x
VE / CA 20239.79x
Number of employees35,000
Floating99.7%

Chart ELI LILLY AND COMPANY


Hard :

Period:




Eli Lilly and Company : Chart technical analysis Eli Lilly and Company |  Market area

Trends technical analysis ELI LILLY AND COMPANY

Short termMiddle termLong term
TrendsBearishbullishbullish

Evolution of the Income Statement

Sale

Purchase

Average recommendationACCUMULATE
Number of Analysts23
Last Closing Price$301.32
Average price target$326.86
Deviation / Average Target8.48%

Officers and Directors




Source link -88